A statistical approach for identifying single nucleotide variants that affect transcription factor binding
1 May 2024·
,,·
0 min read
Nina Baumgarten
Laura Rumpf
Thorsten Kessler
Marcel H. Schulz
Abstract
Non-coding variants located within regulatory elements may alter gene expression by modifying transcription factor (TF) binding sites, thereby leading to functional consequences. Different TF models are being used to assess the effect of DNA sequence variants, such as single nucleotide variants (SNVs). Often existing methods are slow and do not assess statistical significance of results. We investigated the distribution of absolute maximal differential TF binding scores for general computational models that affect TF binding. We find that a modified Laplace distribution can adequately approximate the empirical distributions. A benchmark on in vitro and in vivo datasets showed that our approach improves upon an existing method in terms of performance and speed. Applications on eQTLs and on a genome-wide association study illustrate the usefulness of our statistics by highlighting cell type-specific regulators and target genes. An implementation of our approach is freely available on GitHub and as bioconda package.
Type
Publication
iScience

Authors
Nina Baumgarten
(she/her)
Postdoc
I am a bioinformatician with a diverse background in analyzing genetic and epigenetic data. I have had the chance to work on a variety of projects since I joined the lab, like decoding the effect of non-coding variations, analysing GWAS data, and studying TF binding. Recently, my focus has been shifted toward spatial transcriptomics, which allows me to map genetic findings directly onto tissue architecture. I am motivated by the possibility that these data-driven insights might lead to a better understanding of complex diseases. In my free time, I love spending time in nature for hiking—it’s where the best ideas come to me!

Authors
Laura Rumpf
(she/her)
PhD student
I’m a computer scientist by training who found my way into bioinformatics during my master’s. My work focuses on understanding enhancer–gene regulation using machine learning and single-cell transcriptomic and epigenomic data. I’m particularly interested in how computational models can help uncover regulatory mechanisms and translate these insights into disease-related questions in computational medicine. Outside the lab, I’m usually fueled by coffee and a slightly too serious interest in latte art.